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Abstract
Helium is a low-density inert gas whose physical properties are very different from those of nitrogen and oxygen.
Such properties could be clinically useful in the adult critical care setting, especially in patients with upper to more
distal airway obstruction requiring moderate to intermediate levels of FiO2. However, despite decades of utilization
and reporting, it is still difficult to give any firm clinical recommendation in this setting. Numerous case reports are
available in the context of upper airway obstruction of different origins, but there is a lack of controlled studies for
this indication. One study reported a helium-induced beneficial effect on surrogates of work of breathing after
extubation in non-COPD patients, possibly in relation to laryngeal consequences of tracheal intubation.
Physiological benefits of helium-oxygen breathing have been demonstrated in the context of acute severe asthma,
but there is a lack of large controlled studies demonstrating an effect on pertinent clinical endpoints, except for a
study reported only as an abstract, which mentioned a reduction in the intubation rate in helium-treated patients.
Finally, there are a number of physiological studies in the context of COLD-COPD patients demonstrating a
beneficial effect, mainly by a reduction in the resistive inspiratory work of breathing but also by a reduction in
hyperinflation. Reduction of hypercapnia was mainly observed in spontaneously breathing and noninvasively
ventilated helium-treated patients but not in intubated patients during controlled ventilation, suggesting that the
decrease in PaCO2 was mainly in relation to a diminution in CO2 production, related to the diminution in work of
breathing and not an improved alveolar ventilation. Moreover, there is little evidence that helium-oxygen could
improve parameters of heterogeneity in such patients. Two RCTs were unable to demonstrate a reduction in the
intubation rate in such setting, but they were likely underpowered. An adequately powered international
multicentric study is ongoing and will help to determinate the exact place of the helium-oxygen mixture in the
future. The place of the mixture during the weaning period will deserve further evaluation.
Introduction
Helium is an inert gas whose physical properties are
very different from those of nitrogen and oxygen. Such
properties led to consider its use in various medical
conditions since the first publication by Barach in the
1930s [1]. The purpose of this review was to detail part
of these clinical uses, focusing mainly on obstructive
respiratory diseases in the adult critical care setting, and
therefore excluding pediatric studies and also studies
solely centered on helium-driven nebulization.
Theoretical and practical considerations
Helium is the second element in the universe, after
hydrogen. It is found in very high amounts in the stars.
In the earth, helium can be found in very low quantities
in the atmosphere and in natural gas fields, or it can be
extracted from cleveite, a mineral found in uranium
deposits.
The main property of helium–compared with oxygen
and nitrogen–is its very low density, as assessed by a
volumic mass of 0.18 (in a gaseous state at 0°C) com-
pared with volumic masses of 1.49 and 1.25 for oxygen
and nitrogen, respectively. The low density of helium
can exert important potential benefits with regards to
the airway’s dynamic of fluids:
￿ Mainly, transition of turbulent to laminar flows: as a
theoretical example, the density (d) of the mixture is an
important determinant of the Reynold’sn u m b e r ;w h i c h
indicates the type of flow in a perfect pipe: R = (V.D.d)/
h; where V is the mean linear velocity, D is the diameter
of the pipe, d is the density of the fluid, and h is the
dynamic viscosity of the fluid. When the Reynold’s num-
ber falls below the 2000 limit, the flow becomes laminar.
Because a laminar flow generates much less resistances,
use of helium could be of benefit. Inspiratory flow is
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proximal trachea, but in obstructive diseases, such as
asthma and COLD/COPD, turbulent flow can be
observed more distally in the bronchial tubing.
￿ Reduction of resistances even in cases of persistent
turbulent conditions of flow. Indeed, in cases of turbu-
lent flow, resistances are linearly proportional to the
density of the mixture and to the flow value and inver-
sely proportional to the diameter of the pipe at the fifth
power.
Another important point to consider, although some-
times neglected, is the 14% higher viscosity of helium
compared with nitrogen. In cases of pure laminar flow,
s u c hap r o p e r t yd i r e c t l yi n c r e a s e st h er e s i s t a n c e s ,a s
shown by the Poiseuille’sl a w :R=( 8 . l .h)/Π.r
4 (where R
is the resistance, l is the length of the pipe, h is the visc-
osity, and r its radius). This could potentially increase
part of the respiratory resistances, because of a larger
cross-sectional area flow is mainly laminar in the distal
airways, even in obstructive diseases. Moreover, this
might have additional clinical implications both for
research purpose as well as for care and monitoring,
because flow and volume are sometimes measured by
methods that need a correcting factor for viscosity (i.e.,
via pneumotachograph). More generally, useful publica-
tions are available that describe the consequences of the
use of helium both for mechanical ventilators and for
monitoring devices, such as capnometers [2,3].
A third point to consider is the higher thermic con-
ductivity of helium compared with to oxygen and nitro-
gen. Theoretically, this could favor thermic losses in
helium-treated patients. However, to the best of our
knowledge, such a complication has never been
described in the adult clinical setting and has only been
described in children breathing helium-oxygen via a
Hood administration system [4]. This also has conse-
quences for some types of monitoring devices.
From all the above-mentioned reasons, one can con-
sider that the low density of the mixture could exert
many beneficial effects in cases of airway obstruction:
￿ mainly by a diminution in the resistive inspiratory
work of breathing
￿ but also by reducing expiratory resistances, leading
to less hyperinflation and therefore diminishing elastic
inspiratory work of breathing and putting inspiratory
muscles in a more favorable geometric configuration
￿ hypothetically by a redistribution of the gas through-
out the lungs, in relation to modifications in time-
constants
￿ and also by reducing arterial tension in CO2 through
different mechanisms: 1) diminution in CO2 production,
via a reduction in the total work of breathing; 2)
hypothetically an increase in alveolar ventilation
(through a reduction in CO2 dead-space facilitated by a
better diffusion of CO2 in the low-density helium-oxy-
gen mixture; and 3) a reduction in the so-called pendel-
luft phenomenon, linked to heterogeneous parenchymal
viscoelastic properties of the lung
Importantly, the beneficial effects of helium are likely
to be observed at low or intermediate FiO2. As a conse-
quence, the better candidates for a beneficial effect are
patients with upper airways obstruction, severe asthma
patients and decompensated COPD or COLD patients,
all demonstrating very high respiratory resistances and
usually requiring less than 50% FiO2 under mechanical
ventilation. For each of these situations, we will resume
the available data, both from a physiopathological point
of view but also with consideration of major clinical
endpoints.
Upper airway obstruction
Upper airway obstruction, especially if transient, is prob-
ably one of the better potential indications of helium-
oxygen breathing. Some case reports are available that
describe a beneficial use of the mixture in spontaneously
breathing patients, mainly in the pediatric literature but
also in adult patients: the potential indications are
malignancies [5], bilateral vocal cord dysfunction com-
plicating short-term intubation [6], or radiation therapy
[7,8]. Unfortunately, available data are generally limited
to the description of clinical courses in small numbers
of patients, without helium-free controlled periods and/
or measurement of pertinent physiological parameters,
such as the work of breathing or airway resistances.
Interestingly, Jaber and coworkers performed a physio-
logical study during the postextubation period that com-
pared short periods of air-breathing and helium-oxygen
breathing in 18 non-COPD patients [9]. They mainly
found a helium-associated reduction in the transdiaph-
ragmatic pressure inspiratory swings and in the pres-
sure-time index (these two parameters are surrogates of
the work of breathing) as well as an improvement in the
comfort score of the patients. Such a benefit could be in
relation to a beneficial effect of helium-oxygen breathing
on clinically latent postintubation upper airway obstruc-
tion related to laryngeal injuries [10].
Asthma
Numerous case studies have been published in the setting
of acute severe asthma, reporting favorable outcomes.
Unfortunately, no firm conclusion can be drawn from
such cases with regard to the interest to add helium-oxy-
gen breathing, systematically or as a rescue therapy, to
the standard treatment of acute severe asthma. More rig-
orously, Manthous et al. studied in the emergency setting
27 patients with acute asthma exacerbation who received
standard treatment (beta-agonist aerosols and intrave-
nously administered methylprednisolone); 16 patients
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remaining 11 patients acted as a control group [11]. The
authors documented in the helium-oxygen group a more
marked fall in the pulsus paradoxus and a greater
improvement in the peak expiratory flow (measured via a
helium-oxygen calibrated peak flow meter) than in the
control group. In another study, 23 patients with acute
severe asthma were randomized in the emergency
department to breathe air-oxygen or helium-oxygen in
addition to standard treatment [12]. The authors docu-
mented a more rapid improvement during the first hour
(as assessed by the peak-flow and the dyspnea score) in
the helium-oxygen group, without clinically significant
differences between the two groups beyond this time-
point. Finally, Sattonnet et al. performed a randomized,
multicenter, controlled study in the prehospital setting in
203 patients with acute severe asthma who needed hospi-
talization in the ICU [13]. The authors reported in an
abstract a significant difference in the intubation rate in
favor of helium-oxygen: 7% versus 1%. They also reported
a diminution in the ICU length of stay compared with the
control group.
Altogether, there is to date no firm argument in favor
of systematic administration of helium-oxygen therapy
for acute severe asthma, as confirmed by a meta-analysis
of ten randomized, controlled trials (seven involving
adult patients), including 544 acute asthma patients
[14]. The helium-oxygen mixture could be of value in
the more severe patients, who might be at risk of intu-
bation, while awaiting the effects of standard therapy.
However, the level of evidence seems too low to recom-
mend firmly its administration in this setting. Interest-
ingly, no data are available regarding the use of a
combination of helium-oxygen and noninvasive ventila-
tion in such a situation.
COLD and COPD
The available amount of clinically relevant data is higher
in COPD/COLD exacerbations than in the two previous
situations, with well-performed physiological studies but
also with published RCTs assessing pertinent clinical
endpoints. We will discuss three different situations: 1)
use of helium during spontaneous breathing and/or
noninvasive ventilation in cases of acute exacerbation; 2)
use of helium during invasive ventilation; and 3) use of
helium during the weaning period.
Use of helium during spontaneous breathing and/or
noninvasive ventilation in cases of acute exacerbation
Gerbeaux et al. reported provocative results obtained in
81 decompensated COPD patients in the emergency set-
ting [15]. Forty-two patients received standard treat-
ment, whereas helium-oxygen during spontaneous
breathing was administered in the 39 remaining
patients. Unfortunately, the study was observational and
the administration of helium-oxygen was not rando-
mized but kept at the discretion of the physician in
charge. However, no significant difference was found at
admission between the two groups with regards to any
of the relevant clinical parameters. The authors reported
impressive results with regards to intubation rates (50%
in the control group vs. 8% in helium-oxygen group)
compared with the mortality rates (24% and 3% respec-
tively) and finally with regards to the ICU and hospital
lengths of stay for survivors. Unfortunately, the nonran-
domized design of this monocentric study precludes any
firm clinical recommendation in favor of the use of
helium-oxygen breathing in such a situation. To date,
no confirmation study of these results is available.
Jolliet et al. evaluated the interest of helium-oxygen in
combination with pressure-support noninvasive ventila-
tion in 19 decompensated COPD patients [16]. They
compared three different situations: air-oxygen while
spontaneously breathing, air-oxygen pressure support,
and helium-oxygen pressure support. They reported
beneficial effects of helium-oxygen pressure support not
only in comparison with the spontaneously breathing
periods but also in comparison with the conventional
pressure support period, mainly with regard to the dys-
pnea Borg scale.
Jaber et al. extended these data in a comparable set-
ting while studying ten COPD patients at two different
levels of pressure support during noninvasive ventilation
[17]. They mainly reported a helium-oxygen-associated
diminution in the inspiratory work of breathing com-
pared with air-oxygen periods. They also reported a
beneficial effect in terms of PaCO2 decrease during the
helium-oxygen periods.
Finally, two multicenter RCTs were performed aiming
to demonstrate a reduction in the intubation rate in
exacerbation of COPD/COLD patients [18,19]. Jolliet et
a l .i n c l u d e d1 2 3C O P Dp a t i e n t sa n dM a g g i o r ee ta l .
included 204 COLD patients. The intubation rates were
20.3% and 13.5% in the air and helium-oxygen groups,
respectively, in the study by Jolliet et al. The intubation
rates were 30.4% and 24.5%, respectively, in the study by
M a g g i o r ee ta l .T h e s ed i f f e r e n c e sw e r en o ts t a t i s t i c a l l y
significant. As secondary endpoints, the two groups of
investigators reported a beneficial effect of helium-oxy-
gen in term of improvements of pH and PaCO2 values.
Jolliet et al. also performed a cost analysis, which
favored the use of helium-oxygen, mainly because a
shorter duration of mechanical ventilation and a shorter
ICU and hospital length of stay. Finally, it is likely that
t h et w os t u d i e sw e r eu n d e r p o w e r e dt od e m o n s t r a t ea
difference in the principal endpoint.
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Tassaux et al. performed a study in 23 decompensated
intubated COPD patients that compared two periods of
air-oxygen ventilation to one period of helium-oxygen
ventilation; all other parameters remained unchanged
[20]. They mainly found helium-associated significant
reductions in Pmax, static intrinsic PEEP (staticPEEPi),
and trapped volume. There were no differences in oxy-
genation values, CO2 value, or any hemodynamic para-
meter. Gainnier et al. performed a study in 23 intubated
COPD patients that compared two periods of air-oxygen
and helium-oxygen [21]. They reported a decrease in
work of breathing, implying its resistive and elastic com-
ponents as a decrease in staticPEEPi.
T h e s ed a t aw e r ee x t e n d e db yas t u d yo fo u rg r o u p
including 13 COPD patients [22]. We used a similar
design than in the study by Tassaux [20]. We similarly
found significant reductions in Pmax and in staticPEEPi,
although the latest was less pronounced than in the
study by Jolliet et al. (Table 1). Accordingly, we found
no differences in oxygenation values, PaCO2 values, as
well as in physiological dead-space. Finally, we took the
opportunity to test the hypothesis that helium-oxygen
could improve the heterogeneity of ventilation in such
patients. As previously reported in similar patients, we
observed during air-oxygen ventilation major differences
between staticPEEPi and dynamic intrinsic PEEP (dyn-
PEEPi) [23]. Interestingly, helium induced a small
diminution in each of these parameters, whereas the
dynPEEPi/staticPEEPi ratio remained unchanged. The
dynPEEPi/staticPEEPi ratio is thought to be related to
regional differences in mechanical properties within the
lung–a phenomenon often referred as pendelluft–and/or
viscoelastic pressure losses [22]. To date, there is no
useful clinical way to appreciate separately the absolute
magnitude and the relative contribution of each of these
two factors, but one can reasonably consider that
helium-oxygen had little influence on this global index
of heterogeneity. Supporting this interpretation is the
fact that we also observed no significant change in the
difference in pressure between the pressure (P1)
observed during an inspiratory pause after the rapid
initial fall in pressure, at the first point of zero flow, and
the pressure observed after 5 seconds of occlusion (Ppl).
As for the dynPEEPi/staticPEEPi ratio, (P1 -P p l )c a nb e
attributed both to pendelluft and stress relaxation.
Finally, Tassaux et al. studied ten recovering intubated
COPD patients while ventilated with pressure support
[24]. They consistently reported a helium-induced
reduction in PEEPi, in the number of ineffective breaths,
in inspiratory effort, and in work of breathing for a
given level of pressure support.
Use of helium during the weaning period
We performed a study in 13 severe intubated COPD
patients at the end of the weaning process, measuring
ventilatory variables and work of breathing just before
extubation during two periods of air-oxygen and
helium-oxygen [25]. Repetition of the measurements
was possible in five patients after extubation. Before
extubation, we observed mainly a diminution in the
total work of breathing as well as in its resistive compo-
nent. We also found a significant decrease in PEEPi dur-
ing helium-oxygen breathing. Similar results were
observed after extubation in the five patients who toler-
ated the repetition of measurements. Interestingly, we
found that the absolute reduction in work of breathing
was correlated with the basal value during air-oxygen
breathing. We also observed that one of the patients
exhibiting the lowest levels of WOB during air/oxygen
breathing experienced an increase in WOB with the
helium-oxygen mixture. This was perhaps in relation to
a predominantly distal airway obstruction with a deleter-
ious effect of the mixture possibly in relation with its
higher viscosity compared with air-oxygen. Altogether,
these results emphasized the need to search for predic-
tors useful to identify responders to helium-oxygen
breathing, because the physiological response could be
variable for a patient to another, with possibility of det-
rimental effects.
Conclusions and perspectives
Despite decades of reports and utilization, the exact
place of helium-oxygen in the adult critical care setting
is still not well-defined, although many studies suggest a
potential benefit in upper airway obstruction, in severe
asthma, and in exacerbations of COPD/COLD. The
main body of evidence is found in COPD-COLD
Table 1 Results obtained during three periods of 1 hour
of controlled mechanical ventilation in 13 COPD patients
during the first 24 after intubation
First period
air-oxygen
Second period
helium-oxygen
Third period
air-oxygen
Pmax, cmH2O 35.4 ± 6.7 31.6 ± 7.6* 34.9 ± 6.9
Ppl, cmH2O 22.3 ± 4.9 20.9 ± 5.5* 21.7 ± 4.7
P1 - Ppl, cmH2O 4.5 ± 2.2 4.7 ± 1.7 4.6 ± 2.3
statPEEPi, cmH2O 11.7 ± 4.0 10.3 ± 4.3* 10.9 ± 3.8
dynPEEPi, cmH2O 3.1 ± 1.0 2.7 ± 0.7* 3.0 ± 0.8
PaO2, mmHg 77 ± 12 79 ± 15 80 ± 12
PaCO2, mmHg 59 ± 12 62 ± 14 61 ± 14
VD/VT, % 71 ± 6 69 ± 5 69 ± 7
Ppl = plateau pressure measured after an endinspiratory pause of 5 sec; P1 -
Ppl = difference between the pressure (P1) measured after the rapid initial fall
in pressure during an inspiratory pause, at the first point of zero flow, and Ppl;
statPEEPi = static intrinsic PEEP; dynPEEPi = dynamic intrinsic PEEP; VD/VT =
physiological dead-space.
Results are expressed as mean ± SD.
*Indicates a significant difference at the 0.05 level.
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small series but also a consequent number of rigorous
physiological study and RCTs. In the future, it will be
important to consider the results of an international
ongoing adequately powered RCT designed to evaluate
helium-oxygen not only in combination with noninva-
sive ventilation, but also during the noninvasive free
periods of spontaneous breathing (ClinicalTrials.gov
identifier: NCT01155310). It also will be important to
consider further evaluation of the clinical benefit of the
mixture in the weaning period.
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